Artificial Teeth Billed “Per Tooth”; Clarification on Fractional Treatment in Disputed Interpretations (May 8, 2026) – Shakaihoken Kenkyusho

News Summary

Effective May 8, 2026, a disputed interpretation has clarified that artificial teeth in insured medical care are to be billed on a “per tooth” basis. This resolves previous ambiguities in the interpretation of fractional treatment, leading to expectations of more standardized operations. This revision pertains to the billing standards for dental medical fees and may impact the management of dental institutions that produce and fit prosthetics (artificial teeth).

Perspective from M&A Medical Editorial Department

While the clarification of billing units for artificial teeth may seem like a minor revision to individual medical fees, it is an issue that can indirectly affect the stability of revenue structures and future business valuations for medical institutions, particularly dental clinics. For instance, the clear standard of “per tooth” in insured medical care not only strengthens the basis for calculating material and laboratory costs but also means that material yield and the precision of laboratory instructions directly impact revenue. When considering M&A, such detailed operational aspects of medical fees are crucial checkpoints during due diligence (DD) for evaluating the accuracy and sustainability of revenue. For medical corporations operating multiple clinics, a unified understanding and application of billing standards will enhance the accuracy of group-wide revenue management, ultimately leading to increased credibility in business valuation during succession.

Points Highlighted by This News

• The billing unit for artificial teeth has been clarified as “per tooth,” standardizing the interpretation of fractional treatment.
• Billing standards for dental medical fees have been organized, contributing to improved accuracy in revenue management related to prosthetics.
• This serves as a checkpoint for evaluating revenue accuracy and sustainability in M&A due diligence.
• The detailed operational realities of insured medical care suggest a potential impact on business valuation during succession.

Practical Questions Arising from This News

• Is there a possibility of retrospective claims for past billing errors due to this revision?
• How does this clarification affect the billing of material and laboratory costs for artificial teeth?
• How will the “per tooth” billing practice be confirmed during M&A due diligence?

If You Feel “I Should Consult Too?”

If your clinic is a dental practice and you have any uncertainties or see room for improvement in the billing of artificial teeth under insured medical care, or in the management of associated material and laboratory costs, it is worth considering consulting with a specialist at this time. Especially if you are considering future business succession or M&A, a precise understanding of your revenue structure and the clarification of supporting billing standards are essential for smooth transactions and fair valuation. At M&A Medical, advisors well-versed in these operational aspects of medical fees provide optimal advice tailored to your clinic’s situation.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success-fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultation here